会议论文详细信息
13th South-East Asian Congress of Medical Physics 2015 | |
The implementation in-house dose verification for IMRT and VMAT on breast cancer and NPC cases | |
物理学;医药卫生 | |
Azzi, A.^1 ; Dimitri, F.Y.^2 ; Pawiro, S.A.^1 | |
Medical Physics and Biophysics Division, Department of Physics, Faculty of Mathematics and Natural Sciences, University of Indonesia, Depok, West Java | |
16424, Indonesia^1 | |
Siloam Hospital TB Simatupang, South Jakarta, DKI Jakarta | |
12410, Indonesia^2 | |
关键词: Breast Cancer; Dose distributions; Dose verification; GafChromic films; In-house algorithms; Measurement methods; Optimal results; Rando phantom; | |
Others : https://iopscience.iop.org/article/10.1088/1742-6596/694/1/012014/pdf DOI : 10.1088/1742-6596/694/1/012014 |
|
学科分类:卫生学 | |
来源: IOP | |
【 摘 要 】
IMRT and VMAT have been widely implemented on breast cancer and NPC cases. Dose verification was conducted to ensure the comparison between dose delivered and prescribe dose in TPS to obtain optimal results and the dose delivered. The gafchromic films measurement was done for breast and NPC simulation on RANDO Phantom, irradiating film by 6 MV photon with 200 cGy and scanned with EPSON V700 using 72 dpi. Dose distribution was calculated using the MATLAB-based in-house algorithm. In order to evaluate the gamma index, gafchromic films and MatriXX 2D array were placed in the Multi Cube and irradiated with EPID in same position. Dose distribution differences for IMRT and VMAT with modalities to TPS on film was 5.34% and 6.68% for NPC PTV70; 12.81% and 6.15% for NPC PTV50; 11.14% and 10.80% for breast cancer. Gamma index differences on IMRT with modalities to MatriXX 2D array and EPID was -0.09% and 5.13% for NPC; 0.51% and 2.28% for breast cancer. On the other hand, gamma index difference on VMAT was -1.65% and 1.43% for NPC; 0.19% and 4.38% for breast cancer. This measurement method can be used to verify dose for breast cancer and NPC cases in IMRT and VMAT.【 预 览 】
Files | Size | Format | View |
---|---|---|---|
The implementation in-house dose verification for IMRT and VMAT on breast cancer and NPC cases | 1048KB | download |